131 related articles for article (PubMed ID: 2508783)
1. The influence of interferon alpha and gamma, singly or in combination on human natural cell mediated cytotoxicity.
Rawlinson L; Dalton BJ; Rogers K; Rees RC
Biosci Rep; 1989 Oct; 9(5):549-57. PubMed ID: 2508783
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of natural killer cytotoxicity by alpha or gamma natural and recombinant interferons and interferon inducers. Effect of monocytes.
Platsoucas CD; Fernandes G; Good RA; Gupta S
Int Arch Allergy Appl Immunol; 1986; 79(1):1-7. PubMed ID: 3079737
[TBL] [Abstract][Full Text] [Related]
3. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
Platsoucas CD; Oleszak EL; Good RA
Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
6. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
7. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.
Takeda A; Minato N; Kano S
Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon.
Weigent DA; Langford MP; Fleischmann WR; Stanton GJ
Infect Immun; 1983 Apr; 40(1):35-8. PubMed ID: 6403469
[TBL] [Abstract][Full Text] [Related]
9. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma.
Wallach D
Cell Immunol; 1983 Feb; 75(2):390-5. PubMed ID: 6403252
[TBL] [Abstract][Full Text] [Related]
11. The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins.
Gustafsson A; Sundström S; Lundgren E
J Immunol; 1986 Jul; 137(1):167-71. PubMed ID: 3086447
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
Ostensen ME; Thiele DL; Lipsky PE
J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of beta- and gamma-interferons on natural killer cell-mediated lysis of lung carcinoma cells.
Krishnamurti C; Ahrens P; Ankel H
Immunobiology; 1987 Mar; 174(2):221-32. PubMed ID: 3110053
[TBL] [Abstract][Full Text] [Related]
15. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
16. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
Brooks CG; Holscher M; Urdal D
J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
[TBL] [Abstract][Full Text] [Related]
17. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
18. Influence of lectin-free interleukin-2 on natural and antibody-dependent cellular cytotoxicity.
Kimber I; Bakács T; Roberts K; Moore M
J Clin Lab Immunol; 1984 Oct; 15(2):77-84. PubMed ID: 6440995
[TBL] [Abstract][Full Text] [Related]
19. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.
Svedersky LP; Shepard HM; Spencer SA; Shalaby MR; Palladino MA
J Immunol; 1984 Aug; 133(2):714-8. PubMed ID: 6203975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]